Templated open flocs of nanorods for enhanced pulmonary delivery with pressurized metered dose inhalers
- PMID: 18758922
- DOI: 10.1007/s11095-008-9707-z
Templated open flocs of nanorods for enhanced pulmonary delivery with pressurized metered dose inhalers
Abstract
Purpose: A novel concept is presented for the formation of stable suspensions composed of low density flocs of high aspect ratio drug particles in hydrofluoroalkane (HFA) propellants, and for subdividing (templating) the flocs with aerosolized HFA droplets to achieve high fine particle fractions with a pressurized metered dose inhaler.
Methods: Bovine serum albumin (BSA) nanorods, produced by thin film freezing (TFF), were added to HFA to form a suspension. Particle properties were analyzed with an Anderson cascade impactor (ACI), static and dynamic light scattering and optical microscopy.
Results: The space filling flocs in HFA were stable against settling for one year. The pMDI produced high fine particle fractions (38-47%) with an emitted dose of 0.7 mg/actuation. The atomized HFA droplets break apart, that is template, the highly open flocs. Upon evaporation of HFA, capillary forces shrink the templated flocs to produce porous particles with optimal aerodynamic diameters for deep lung delivery.
Conclusions: Open flocs composed of nanorods, stable against settling, may be templated during actuation with a pMDI to produce optimal aerodynamic diameters and high fine particle fractions. This concept is applicable to a wide variety of drugs without the need for surfactants or cosolvents to stabilize the primary particles.
Similar articles
-
Templated open flocs of anisotropic particles for pulmonary delivery with pressurized metered dose inhalers.J Pharm Sci. 2010 Jul;99(7):3150-65. doi: 10.1002/jps.22091. J Pharm Sci. 2010. PMID: 20187139
-
Influence of propellant composition on drug delivery from a pressurized metered-dose inhaler.Drug Dev Ind Pharm. 1998 Aug;24(8):763-70. doi: 10.3109/03639049809082724. Drug Dev Ind Pharm. 1998. PMID: 9876524
-
Investigation of some commercially available spacer devices for the delivery of glucocorticoid steroids from a pMDI.Drug Dev Ind Pharm. 2001 May;27(5):401-12. doi: 10.1081/ddc-100104315. Drug Dev Ind Pharm. 2001. PMID: 11448047
-
A Review of Methods for Evaluating Particle Stability in Suspension Based Pressurized Metered Dose Inhalers.Curr Pharm Des. 2015;21(27):3955-65. doi: 10.2174/1381612821666150820110153. Curr Pharm Des. 2015. PMID: 26290200 Review.
-
The rejuvenated pressurised metered dose inhaler.Expert Opin Drug Deliv. 2007 May;4(3):215-34. doi: 10.1517/17425247.4.3.215. Expert Opin Drug Deliv. 2007. PMID: 17489650 Review.
Cited by
-
Building membrane emulsification into pulmonary drug delivery and targeting.Pharm Res. 2010 Nov;27(11):2505-8. doi: 10.1007/s11095-010-0240-5. Epub 2010 Aug 12. Pharm Res. 2010. PMID: 20703894 No abstract available.
-
Preparation of Naringenin Nanosuspension and Its Antitussive and Expectorant Effects.Molecules. 2022 Jan 24;27(3):741. doi: 10.3390/molecules27030741. Molecules. 2022. PMID: 35164006 Free PMC article.
-
Progress on Thin Film Freezing Technology for Dry Powder Inhalation Formulations.Pharmaceutics. 2022 Nov 28;14(12):2632. doi: 10.3390/pharmaceutics14122632. Pharmaceutics. 2022. PMID: 36559129 Free PMC article. Review.
-
Controlled delivery systems: from pharmaceuticals to cells and genes.Pharm Res. 2011 Jun;28(6):1241-58. doi: 10.1007/s11095-011-0392-y. Epub 2011 Mar 19. Pharm Res. 2011. PMID: 21424163 Review.
-
Respirable low-density microparticles formed in situ from aerosolized brittle matrices.Pharm Res. 2013 Mar;30(3):813-25. doi: 10.1007/s11095-012-0922-2. Epub 2012 Nov 15. Pharm Res. 2013. PMID: 23229856
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources